MedTrace Logo

Under- and Overdiagnosis in BreastScreen Norway

NCT03852953 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3915

Last updated 2024-08-28

No results posted yet for this study

Summary

This PhD project will describe tumour characteristics and survival associated with of under- and overdiagnosed breast cancers, the rate of overdiagnosis in BreastScreen Norway, and whether women and family doctors are aware of, and knowledgeable about, under- and overdiagnosis in breast cancer screening.

Conditions

Interventions

OTHER

Under- or overdiagnosed cancer

Diagnosed with a cancer that was visible on prior mammograms

OTHER

Screening

Invited or attended BreastScreen Norway

Sponsors & Collaborators

  • Extrastiftelsen

    collaborator OTHER

  • Norwegian Institute of Public Health

    lead OTHER_GOV

Principal Investigators

  • Solveig Hofvind, PhD · Norwegian Institute of Public Health

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2020-06-08
Completion
2020-06-08

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03852953 on ClinicalTrials.gov